Matthew Rabinowitz, Natera’s Co-Founder and Executive Chairman, shared on LinkedIn:
“Today marks an important moment for Natera.
I founded the company with a simple belief: every family deserves access to technologies that offer early detection of disease. Roughly twenty years later, I’m incredibly proud of what this company has become.
I want to thank Steve Chapman for his excellent leadership. Since joining Natera in 2010, and as CEO since 2019, Steve helped grow Natera from a prenatal testing company into a global leader in precision medicine across women’s health, oncology and organ health.
His impact on our business, our team and millions of patients will last for years.
We’re thrilled to welcome Solomon Moshkevich as the company’s next CEO. In 15 years at Natera, Solomon has helped build nearly every part of our business and was one of the instrumental leaders in our expansion into oncology. He leads with integrity, rigor and a natural competitive spirit. I can think of no one better to lead Natera into its next chapter.
And for the second consecutive time, an internal leader is stepping into the CEO role. This is a testament to the depth of this extraordinary team that we have built.
Congratulations, Solomon, and thank you, Steve.”
Natera Announces Leadership Transition.
You can also read: Solomon Moshkevich Named CEO of Natera.
